Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression.

导出原文传递

翻译打印收藏纠错

作者： Juliana,Surjan ^[1] ; Julia Diniz,Grossi ^[2] ; José Alberto,Del Porto ^[1] ; Rodrigo Simonini,Delfino ^[1] ; Raphael,de Oliveira Cerqueira ^[1] ; Ana Cecília,Lucchese ^[3] ; Eduardo,Magalhães ^[3] ; Lorena Catarina,Del Sant ^[3] ; Marco Aurélio,Tuena ^[3] ; Carolina,Nakahira ^[3] ; Victor Augusto Rodovalho,Fava ^[3] ; Matheus Souza,Steglich ^[1] ; Guilherme Lozi,Abdo ^[1] ; Matheus Ghossain,Barbosa ^[3] ; Luciana Maria,Sarin ^[3] ; Acioly Luiz Tavares,Lacerda ^[4]

作者单位： PRODAF-Programa de Transtornos Afetivos, Department of Psychiatry, Federal University of Sao Paulo, Rua Major Maragliano, 241, Vila Mariana, Sao Paulo, SP, 04017-030, Brazil. ^[1] CNS Unit, BR Trials, Sao Paulo, Brazil. ^[2] Centro Alfa de Humanização, Escola Paulista de Medicina, Federal University of Sao Paulo, Sao Paulo, Brazil. ^[3] PRODAF-Programa de Transtornos Afetivos, Department of Psychiatry, Federal University of Sao Paulo, Rua Major Maragliano, 241, Vila Mariana, Sao Paulo, SP, 04017-030, Brazil. acioly@institutosinapse.org. ^[4] CNS Unit, BR Trials, Sao Paulo, Brazil. acioly@institutosinapse.org. ^[5] LiNC-Laboratory of Integrative Neuroscience, Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil. acioly@institutosinapse.org. ^[6]